Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

NCT00049595 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

552

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
BIOLOGICAL: filgrastim
BIOLOGICAL: pegfilgrastim
DRUG: ABVD regimen
DRUG: BEACOPP regimen
DRUG: cyclophosphamide
DRUG: dacarbazine
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: prednisone
DRUG: procarbazine hydrochloride
DRUG: vinblastine sulfate
DRUG: vincristine sulfate

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]